Pharmafile Logo

FIECON

We are global health economics consultancy, committed to launching products that make a difference in people’s lives. We work across a product’s lifecycle, supporting biotech, pharmaceutical, and medical technology companies.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Havas Life London

We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by strategically aligning promotion, medical education and PR across the product…

View Profile

MDNT

MDNT is a native Digital and Omnichannel agency focused solely on the healthcare, pharma, and life science industries. We’re highly experienced, no nonesense, and very good at what we do.

View Profile

Onyx Health

Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national and international reach. As we understand the healthcare market and…

View Profile

OPEN Health

OPEN Health brings together deep scientific knowledge, global understanding, and broad specialist expertise to support our clients in improving health outcomes and patient wellbeing.

View Profile

Sciterion

Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make a positive contribution to patient care. Real world experience of…

View Profile

Company Details

Fiecon, 3 College Yard, Lower Dagnall Street, St Albans, Hertfordshire, AL3 4PA, United Kingdom
01727 225601

 Latest Content from PMHub 

Brand new to PR? Keep calm and pitch on!

Entering the world of public relations (PR) I thought my understanding of what an average day would entail was comprehensive. My first 6 months as a PR professional has shown...

The price of healthy eating

Obesity is extremely prevalent in the UK and in the most recent reports, it has been said that two-thirds of Britons are overweight. Due to this, healthy eating and the...

Is Dr Google a 21st-century necessity?

On 27th September 2018, Google turned 20 years old. Throughout the last two decades, internet users have increasingly turned to Dr Google as a popular search engine to help self-diagnose...

Using storytelling to cut through the chatter in a crowded marketplace

11 women die every day from ovarian cancer. That is more than the number of people who die every day in road accidents. But we’ve never put out a press...

5 Ways to Communicate With Millennials About Healthcare

What does it mean to be a millennial? Opinions vary greatly and it is difficult to disagree on the exact definition. Metro explained the generation as babies born from the...

Webcast: Poker face revealed: Using facial analysis to uncover deeper levels of emotional insight

In the first part of our series covering market research innovations which have value in healthcare, we demonstrate how we've been using facial analysis to delve further into respondents' reactions...

Report: Living with RA (EU, Japan and Canada) 2019 reports

Research Partnership launches new patient Living with  Rheumatoid Arthritis (EU & Japan)  2019 report.r Living with Rheumatoid Arthritis (RA) is a quantitative study conducted online amongst 390 patients diagnosed with RA in...

News: Therapy Watch launches a new wave of EU tracking in Psoriasis (PsO)

A panel of 40 dermatologists in each of the major EU markets reports on patients on advanced therapies including biologics and small molecule therapies every quarter. In addition from Q1...

Emerging Markets: Your Essential Guide

Using our combined knowledge and years of experience of working in these territories our emerging markets experts have produced this essential guide to help address some of the core challenges...

Live webinar: Navigating new frontiers: Ways to find space in the future RA market

In partnership with pharmaphorumThursday 21st March 201915:00 GMT / 16:00 CETRegister now to secure your place »The emergence of low-cost biosimilar versions of Humira and the new janus kinase (JAK) inhibitors,...